Newsletter_02-2024_EN

More documents

Recommendations

Info

EDAG Group: Enormous growth opportunities in new industries The EDAG Group, engineering service provider to the global mobility industry and a technology developer for industrial solutions, focuses more and more on sectors outside the mobility industry. The reason for this is the increasing growth potential, for example in the semiconductor and chemical industries. Coming from the automotive world, the efficient planning, design, optimization and implementation of smart factories and their production facilities, and the associated networked product development, is a quality guarantee of the EDAG Group. For years, customers have relied on the development partner, which scores points for its qualifications, company size, financial stability and international location structure. Dirk Keller, Managing Director of EDAG Production Solutions, is responsible for the strategic orientation and further development of industrial production solutions. „As an engineering service provider, we are not an OEM or plant manufacturer that is primarily focused on selling its products. As an independent company, we can look for the best and most efficient solutions on the market in order to optimally meet customer requirements,“ emphasizes Keller. „Additionally, we develop and implement customized solutions for areas where there is still no adequate alternative on the market.“ EDAG Group Managing Director and CEO Cosimo De Carlo adds: „With our company EDAG Production Solutions, we advise customers and realize complex projects for them in the field of smart factories and manufacturing plants. We are familiar with the challenges, legal requirements and, of course, all relevant issues relating to our customers‘ production, and are able to provide optimum support for the reorganization or optimization of their plants. Knowledge transfer from the automotive industry to other industries Over the last 20 years, the automotive industry has developed into a highly automated and standardized production process. Other industries can benefit immensely from the sector‘s experience. This also applies to the semiconductor industry, for example. Since the coronavirus pandemic, the demand for and production of chips has Dirk Keller is responsible for the strategic orientation and further development of industrial production solutions at the EDAG Group. (Photo: EDAG Group) increased enormously due to growth in information and telecommunications technology products. Increasing electrification and digitalization of all areas of life will ensure growth in the semiconductor industry in the long term: new semiconductor production facilities are being built almost all over the world. „The EDAG Group benefits from these market developments. The semiconductor industry currently accounts for 20 percent of our subsidiary Production Solutions‘ revenue - and this is set a growing trend. Our experience from the automotive industry is extremely helpful here,“ adds Keller. In addition to the semiconductor industry, medical technology is also a growing sales area. Both industries have very high safety and cleanliness standards, and in both industries the clean room is of great importance both for production and for the construction of the plant technology. We have built up a high level of expertise in this area and have already implemented large-scale customer projects for well-known groups in both industries.“ International production networks are particularly interesting and highly scalable for companies. The EDAG Group has a longstanding practice of starting the roll-out in a production facility in Europe. The resulting experience will be used to roll out the system to other plants. EDAG‘s strong sales structure in Europe, with an international team of experts at around 60 locations worldwide, is key to this. The EDAG Group makes use of its local knowledge to respond to individual customer requirements, always monitoring market developments and evaluating new market potential in these industries. This also includes the American market, where the EDAG Group will continue to expand its sales activities in the coming years. EDAG Engineering GmbH D 65205 Wiesbaden www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition EN 02-2024 page 12/23
A research scientist is using a tablet Computer in a modern high-tech laboratory to study genetics. (Source: Bayer AG) Collaboration to focus on cardiovascular diseases and ophthalmology in China Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals Bayer and RTW Investments, LP (“RTW”) today announced an equity investment into Ji Xing Pharmaceuticals Limited (“JIXING”) in the amount of USD 35 million and USD 127 million respectively. JIXING, founded and backed by RTW, is a clinical-stage biopharmaceutical company committed to bringing innovative medicines to Chinese patients with serious and life-threatening diseases. The collaboration will grant Bayer privileged rights to negotiate the commercialization of JIXING’s pipeline assets in the areas of cardiovascular diseases and ophthalmology. In addition to tapping into Bayer’s deep experience in the cardiovascular and ophthalmology fields, the collaboration will leverage the company’s significant presence in China. Bayer and JIXING will also form a joint portfolio strategy committee to explore potential additional business development opportunities, and Xiaolan Zhou, Executive Vice President, Pharmaceuticals Division, Bayer AG, President of Bayer Pharmaceuticals China, President of Bayer Greater China, will join JIXING’s Board of Directors. “Collaborating with RTW is an important step in our ongoing efforts to transform patient care in areas of high unmet medical need,” said Juergen Eckhardt, M.D., Member of the Executive Committee of Bayer’s Pharmaceuticals Division and Head of Business Development, Licensing & Open Innovation and Head of Leaps by Bayer. “With the investment in JIXING, we continue to expand our global network and strengthen our local presence in China.” “JIXING is on an exciting growth trajectory, driven by a worldclass research and development team with a unique understanding of how to most effectively deliver innovative therapies that address complicated diseases to millions of Chinese patients,” said Roderick Wong, Managing Partner and Chief Investment Officer of RTW. “We believe JIXING is well-positioned to achieve its mission to bring breakthrough therapeutics for millions of people across China.” “We are pleased to enter into this strategic partnership with Bayer, a leading multinational pharmaceutical company with a strong presence in China,” said Sandy Mou, Board Executive Director and Chief Executive Officer of JIXING. “Today’s milestones will help, strengthen JIXING‘s capabilities to develop and produce new drugs from preclinical stage to market launch, and enable us to rapidly expand our reach globally. We look forward to continuing to advance and deliver innovative therapies and solutions to patients.” Leaps by Bayer, the impact investment arm of Bayer AG, is joining RTW, who incubated JIXING in 2019, in leading JIXING’s Series D financing. BAYER AG D 51373 Leverkusen www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition EN 02-2024 page 13/23
Page 1 and 2: EN 02/24 Siltronic AG produces firs
Page 3 and 4: State-of-the-art electron beam lith
Page 5 and 6: to the cleanliness specifications t
Page 7 and 8: Effective, dry and cleanroomcompati
Page 9 and 10: AIXTRON‘s neues Innovationszentru
Page 11: need an Offensive 2030.” After al
Page 15 and 16: The Most Protective Lab Glove in th
Page 17 and 18: With a suitable product range, GEM
Page 19 and 20: analytica 2024: a guide to Laborato
Page 21 and 22: Anuga FoodTec 2024, Hall 4.1, Booth
Page 23: New ALLIOLiGHT system lights TUBE A

Newsletter_02-2024_EN

Create successful ePaper yourself

Delete template?

Save as template?